Clinical Trial Update: Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing RPH-075 to Keytruda in unresectable or metastatic skin melanoma is ongoing with undisclosed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Melanoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• RPH-075

Snippet

Sponsor: R-Pharm | Conditions: Skin Melanoma | Phase 3 | Status: UNKNOWN